For example, Tet1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of the PPARα (peroxisome proliferator-activated receptor alpha) promoter 49. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.